查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930096

全球DNA合成市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

DNA Synthesis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 183 Pages | 商品交期: 请询问到货日

价格

DNA合成市场成长驱动因子

受科学研究、诊断和治疗领域对合成DNA需求不断成长的推动，全球DNA合成市场正经历显着成长。根据Fortune Business Insights的资料显示，该市场在2025年的价值为51.9亿美元，预计到2026年将达到59.5亿美元。预计从2026年到2034年，该市场将以19.09%的年复合成长率成长，到2034年达到240.6亿美元，这反映了合成DNA在基因治疗、分子诊断和个人化医疗领域日益广泛的应用。北美在2025年占据市场主导地位，市场占有率高达54.61%。这得益于强大的研发基础设施、精准医疗的高普及率，以及领先企业积极拓展服务和推出创新产品的努力。

DNA合成是指人工合成DNA分子，包括寡核苷酸、基因及DNA片段。这些合成DNA产品能够用于开发新药、疫苗、遗传疾病基因疗法以及分子诊断工具，例如PCR检测和核酸感测器。慢性病、遗传疾病和罕见疾病的日益普遍、医疗保健成本的不断上涨以及人们对个人化治疗意识的增强，推动全球对合成DNA的需求。

市场趋势

技术进步是市场成长的关键驱动力。各公司正致力于开发更快、更准确、更经济高效的DNA合成方法，例如自动化微流控系统，以减少处理时间和人力需求。例如，2023年8月，Atantares公司筹集了1390万美元，用于开发一种用于高通量酶促DNA合成的分子晶片，这体现了自动化和效率提升的趋势。

在新冠疫情期间，由于分子诊断检测和疫苗研发的迫切需求，合成DNA的需求激增。疫情过后，市场趋于稳定，但对精准医疗和基因治疗的日益关注，使其保持了强劲的成长动力。

市场成长驱动因素

市场成长的驱动因素是DNA合成技术在新型疗法、分子诊断、研发领域的广泛应用。特别是基因合成，由于其可客製化的应用，对製药和生物技术公司的需求不断成长。例如，预计到2026年，基因合成领域将占整个市场的74.31%。寡核苷酸合成也因其在诊断、治疗和基因治疗中的应用而备受关注。

医疗保健支出和精准医疗投资进一步推动了市场成长。基因合成技术能够针对癌症和遗传疾病等疾病提供个人化治疗，这与英国等国的政府政策相符。到2025年，英国的公共研发支出将达到273.6亿美元。

市场限制因子

儘管市场成长迅速，但仍面临诸多挑战，例如缺乏明确的监管框架和熟练的实验室人员短缺。例如，2022年9月，欧洲药品管理局（EMA）宣布需要製定合成寡核苷酸指南，这反映出监管方面的不确定性，可能会延迟产品上市。

市场区隔分析

依产品/服务划分：服务细分市场在2026年将占据72.76%的市场占有率，这主要得益于提供高纯度、高性价比客製化DNA解决方案的企业。产品领域（包括仪器、试剂和耗材）也占据了相当大的占有率，这主要得益于Telesis Bio Inc.于2023年5月推出的 "BioXp Select DNA克隆试剂盒" 等新产品的推动。

依类型划分：基因合成占据最大占有率，这主要归功于其可自订的序列以及科研机构和行业的高需求。寡核苷酸合成的成长主要得益于其在诊断、治疗和分子生物学领域日益广泛的应用。

依应用划分：诊断领域将在2026年占据领先地位，市场占有率达50.26%，这主要得益于癌症和传染病分子诊断的推动。治疗领域由于基因治疗和疫苗的研发而成长，而研发领域则透过药物发现、克隆和基因编辑等技术持续扩张。

依最终用户划分：製药和生物技术公司占据最大占有率，它们利用合成DNA开发新型疗法和基因疗法。合约研究组织/合约研发生产组织（CRO/CDMO）紧随其后，提供专业化的生产和服务。学术和研究机构对此类产品的采用率也不断提高。

区域趋势

北美将在2025年以28.3亿美元的市场规模引领市场，预计到2026年将成长至32.2亿美元，这主要得益于慢性病和遗传病的高发生率、先进的研究基础设施以及个性化医疗的不断发展。光是美国市场预计到2026年就将达到30.3亿美元。欧洲也占了相当大的市场占有率，其中英国和德国预计分别达到2.2亿美元和3.2亿美元，这得益于双方强大的研发合作。亚太地区预计将实现最高的年复合成长率，其中中国、日本和印度预计到2026年将分别达到4.3亿美元、2.4亿美元和1.3亿美元，这主要得益于生物技术基础设施的扩张、研究合作的加强以及合成DNA技术的日益普及。拉丁美洲和中东及非洲地区预计将实现温和成长，这主要得益于各国政府主导的加强生物技术研究的措施。

主要公司及趋势

主要市场参与者包括Thermo Fisher Scientific、Integrated DNA Technologies、GenScript、Eurofins Scientific、Azenta、Twist Bioscience。各公司正致力于策略合作、设施扩建和新服务开发。例如，2023年11月，Twist Biosciences推出了 "Twist Express Genes" ，提供快速基因合成和加速递送服务。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • DNA合成技术步骤
  • 关键产业趋势：併购、业务合作等
  • 新产品发布
  • 新冠疫情对DNA合成的影响合成市场

第5章 全球DNA合成市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品/服务划分
    • 产品
      • 设备
      • 试剂及耗材
    • 服务
  • 市场分析、洞察与预测：依类型
    • 寡核苷酸合成
    • 基因合成
  • 市场分析、洞察与预测：依应用
    • 诊断
      • 传染病
      • 癌症
      • 其他
    • 治疗
      • 基因治疗
      • 预防医药
      • 其他
    • 研发
      • 克隆技术、基因编辑
      • 药物发现与开发
      • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 製药和生技公司
    • 合约研究组织（CRO）与合约开发与生产组织（CDMO）
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美DNA合成市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 美国
    • 加拿大

第7章 欧洲DNA合成市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第8章 亚太地区DNA合成市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 其他地区亚太地区

第9章 拉丁美洲DNA合成市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第10章 中东与非洲DNA合成市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司公司简介
    • Thermo Fisher Scientific Inc.
    • Integrated DNA Technologies, Inc.（Danaher）
    • Eurofins Scientific
    • GenScript
    • Azenta, Inc.
    • LGC Limited
    • Biomatik
    • Telesis Bio Inc.
    • Twist Bioscience
    • Bioneer Corporation
Product Code: FBI109799

Growth Factors of DNA synthesis Market

The global DNA synthesis market is witnessing significant growth driven by the rising demand for synthetic DNA in research, diagnostics, and therapeutic applications. According to Fortune Business Insights, the market was valued at USD 5.19 billion in 2025, and it is expected to grow to USD 5.95 billion in 2026. With an anticipated CAGR of 19.09% from 2026 to 2034, the market is projected to reach USD 24.06 billion by 2034, reflecting the increasing adoption of synthetic DNA for gene therapy, molecular diagnostics, and personalized medicine. North America dominated the market in 2025, holding 54.61% market share, due to robust R&D infrastructure, high adoption of precision medicine, and active initiatives by leading companies to expand services and launch innovative products.

DNA synthesis involves the artificial creation of DNA molecules, including oligonucleotides, genes, and DNA fragments. These synthetic DNA products enable the development of new drugs, vaccines, gene therapies for genetic disorders, and molecular diagnostic tools such as PCR assays and nucleic-acid-based sensors. The rising prevalence of chronic, genetic, and rare diseases, along with increased healthcare expenditure and awareness of personalized treatment, is propelling demand for synthetic DNA globally.

Market Trends

Technological advancements have been a significant driver of market growth. Companies are focusing on faster, more accurate, and cost-effective DNA synthesis methods, including automated microfluidics systems, which reduce turnaround time and labor requirements. For example, in August 2023, Atantares raised USD 13.9 million to develop molecular chips for high-throughput enzymatic DNA synthesis, demonstrating the trend toward automation and efficiency.

During the COVID-19 pandemic, demand for synthetic DNA surged due to the urgent need for molecular diagnostic tests and vaccine development. Post-pandemic, the market stabilized, but the increased focus on precision medicine and gene-based therapeutics has maintained strong growth momentum.

Market Growth Factors

The growing use of DNA synthesis in novel therapeutics, molecular diagnostics, and R&D initiatives is driving market expansion. Gene synthesis is particularly in demand due to its customizable applications for pharmaceutical and biotechnology companies. For instance, the gene synthesis segment accounted for 74.31% of the market in 2026. Oligonucleotide synthesis is also gaining traction due to its use in diagnostics, therapeutics, and gene therapy.

Healthcare spending and investments in precision medicine are further enhancing market growth. Gene synthesis allows tailored treatments for diseases such as cancer and genetic disorders, aligning with government initiatives in countries like the U.K., where public R&D spending is projected to reach USD 27.36 billion by 2025.

Market Restraints

Despite rapid growth, the market faces challenges, including a lack of clear regulatory frameworks and a shortage of skilled laboratory personnel. For instance, in September 2022, the European Medicines Agency highlighted the need for guidelines on synthetic oligonucleotides, reflecting regulatory uncertainties that may slow product launches.

Segmentation Analysis

By Product & Service: The services segment dominated the market with 72.76% share in 2026, driven by providers offering high-purity, cost-effective, and customized DNA solutions. The products segment, including instruments and reagents & consumables, also holds a significant portion, bolstered by new launches such as the BioXp Select DNA Cloning kit by Telesis Bio Inc. in May 2023.

By Type: Gene synthesis holds the largest share due to customizable sequences and high demand from research institutions and industry. Oligonucleotide synthesis is growing due to increasing use in diagnostics, therapeutics, and molecular biology applications.

By Application: The diagnostics segment dominated in 2026 with 50.26% market share, driven by molecular diagnostics for diseases such as cancer and infectious diseases. The therapeutics segment is growing due to gene therapy and vaccine development, while R&D continues to expand through drug discovery, cloning, and gene editing initiatives.

By End-User: Pharmaceutical and biotechnology companies hold the largest share, leveraging synthetic DNA for novel therapeutics and gene therapy development. Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) follow closely, offering specialized production and services. Academic and research institutes are also increasing adoption.

Regional Insights

North America dominated with USD 2.83 billion in 2025, growing to USD 3.22 billion in 2026, driven by high prevalence of chronic and genetic diseases, advanced research infrastructure, and increasing personalized medicine initiatives. The U.S. market alone is projected at USD 3.03 billion in 2026. Europe holds a significant market share, with the U.K. and Germany projected to reach USD 0.22 billion and USD 0.32 billion, respectively, in 2026, supported by strong R&D collaborations. The Asia Pacific region is anticipated to witness the highest CAGR, with China, Japan, and India projected at USD 0.43 billion, USD 0.24 billion, and USD 0.13 billion, respectively, in 2026, due to growing biotech infrastructure, research collaborations, and increasing adoption of synthetic DNA technologies. Latin America and the Middle East & Africa are expected to grow moderately, driven by government initiatives to enhance biotechnology research.

Key Players & Developments

Prominent market players include Thermo Fisher Scientific, Integrated DNA Technologies, GenScript, Eurofins Scientific, Azenta, and Twist Bioscience. Companies focus on strategic collaborations, facility expansions, and new service launches. For instance, in November 2023, Twist Bioscience launched Twist Express Genes, offering rapid gene synthesis with accelerated delivery.

Conclusion

The global DNA synthesis market is set for robust growth, expanding from USD 5.19 billion in 2025 to USD 24.06 billion by 2034, driven by technological advancements, growing demand in diagnostics, therapeutics, and research, and increasing investments in synthetic biology. With innovations in gene synthesis, growing adoption of oligonucleotides, and regional expansion, the market is poised to play a critical role in precision medicine and the future of biotechnology worldwide.

Segmentation By Product & Service

  • Products
    • Instruments
    • Reagents & Consumables
  • Services

By Type

  • Oligonucleotide Synthesis
  • Gene Synthesis

By Application

  • Diagnostics
    • Infectious Diseases
    • Cancer
    • Others
  • Therapeutics
    • Gene Therapy
    • Preventive Medicine
    • Others
  • Research & Development
    • Cloning and Gene Editing
    • Drug Discovery & Development
    • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
  • Others

By Region

  • North America (By Product & Service, By Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Developments in the DNA Synthesis
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. New Product Launches
  • 4.4. Impact of COVID-19 on the DNA Synthesis Market

5. Global DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product & Service
    • 5.1.1. Products
      • 5.1.1.1. Instruments
      • 5.1.1.2. Reagents & Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Oligonucleotide Synthesis
    • 5.2.2. Gene Synthesis
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Diagnostics
      • 5.3.1.1. Infectious Diseases
      • 5.3.1.2. Cancer
      • 5.3.1.3. Others
    • 5.3.2. Therapeutics
      • 5.3.2.1. Gene Therapy
      • 5.3.2.2. Preventive Medicine
      • 5.3.2.3. Others
    • 5.3.3. Research & Development
      • 5.3.3.1. Cloning and Gene Editing
      • 5.3.3.2. Drug Discovery & Development
      • 5.3.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product & Service
    • 6.1.1. Products
      • 6.1.1.1. Instruments
      • 6.1.1.2. Reagents & Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Oligonucleotide Synthesis
    • 6.2.2. Gene Synthesis
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Diagnostics
      • 6.3.1.1. Infectious Diseases
      • 6.3.1.2. Cancer
      • 6.3.1.3. Others
    • 6.3.2. Therapeutics
      • 6.3.2.1. Gene Therapy
      • 6.3.2.2. Preventive Medicine
      • 6.3.2.3. Others
    • 6.3.3. Research & Development
      • 6.3.3.1. Cloning and Gene Editing
      • 6.3.3.2. Drug Discovery & Development
      • 6.3.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product & Service
    • 7.1.1. Products
      • 7.1.1.1. Instruments
      • 7.1.1.2. Reagents & Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Oligonucleotide Synthesis
    • 7.2.2. Gene Synthesis
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Diagnostics
      • 7.3.1.1. Infectious Diseases
      • 7.3.1.2. Cancer
      • 7.3.1.3. Others
    • 7.3.2. Therapeutics
      • 7.3.2.1. Gene Therapy
      • 7.3.2.2. Preventive Medicine
      • 7.3.2.3. Others
    • 7.3.3. Research & Development
      • 7.3.3.1. Cloning and Gene Editing
      • 7.3.3.2. Drug Discovery & Development
      • 7.3.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product & Service
    • 8.1.1. Products
      • 8.1.1.1. Instruments
      • 8.1.1.2. Reagents & Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Oligonucleotide Synthesis
    • 8.2.2. Gene Synthesis
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Diagnostics
      • 8.3.1.1. Infectious Diseases
      • 8.3.1.2. Cancer
      • 8.3.1.3. Others
    • 8.3.2. Therapeutics
      • 8.3.2.1. Gene Therapy
      • 8.3.2.2. Preventive Medicine
      • 8.3.2.3. Others
    • 8.3.3. Research & Development
      • 8.3.3.1. Cloning and Gene Editing
      • 8.3.3.2. Drug Discovery & Development
      • 8.3.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product & Service
    • 9.1.1. Products
      • 9.1.1.1. Instruments
      • 9.1.1.2. Reagents & Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Oligonucleotide Synthesis
    • 9.2.2. Gene Synthesis
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Diagnostics
      • 9.3.1.1. Infectious Diseases
      • 9.3.1.2. Cancer
      • 9.3.1.3. Others
    • 9.3.2. Therapeutics
      • 9.3.2.1. Gene Therapy
      • 9.3.2.2. Preventive Medicine
      • 9.3.2.3. Others
    • 9.3.3. Research & Development
      • 9.3.3.1. Cloning and Gene Editing
      • 9.3.3.2. Drug Discovery & Development
      • 9.3.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product & Service
    • 10.1.1. Products
      • 10.1.1.1. Instruments
      • 10.1.1.2. Reagents & Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Oligonucleotide Synthesis
    • 10.2.2. Gene Synthesis
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Diagnostics
      • 10.3.1.1. Infectious Diseases
      • 10.3.1.2. Cancer
      • 10.3.1.3. Others
    • 10.3.2. Therapeutics
      • 10.3.2.1. Gene Therapy
      • 10.3.2.2. Preventive Medicine
      • 10.3.2.3. Others
    • 10.3.3. Research & Development
      • 10.3.3.1. Cloning and Gene Editing
      • 10.3.3.2. Drug Discovery & Development
      • 10.3.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Integrated DNA Technologies, Inc. (Danaher)
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Eurofins Scientific
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. GenScript
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Azenta, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. LGC Limited
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Biomatik
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Telesis Bio Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Twist Bioscience
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Bioneer Corporation
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 02: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 03: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 04: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 05: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 06: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 07: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 08: Global DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 09: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 10: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 11: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 12: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 13: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 15: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 16: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 17: North America DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 18: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 19: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 20: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 21: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 24: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 25: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 26: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 27: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 28: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 29: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 30: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 31: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 32: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 33: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 34: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 35: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 36: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 37: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 38: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 39: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 40: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 42: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 43: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 44: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 45: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 46: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 47: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 48: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 49: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 50: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 51: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 52: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 53: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 54: Middle East & Africa DNA Synthesis Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 01: Global DNA Synthesis Market Revenue Breakdown (USD billion, %), by Region, 2025 & 2034
  • Figure 02: Global DNA Synthesis Market Value Share (%), By Product & Service, 2025 & 2034
  • Figure 03: Global DNA Synthesis Market Value Share (%), By Type, 2025 & 2034
  • Figure 04: Global DNA Synthesis Market Value Share (%), By Application, 2025 & 2034
  • Figure 05: Global DNA Synthesis Market Value Share (%), By End-user, 2025 & 2034
  • Figure 06: Global DNA Synthesis Market Value Share (%), By Region, 2025 & 2034
  • Figure 07: North America DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 08: North America DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 09: North America DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 10: North America DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 11: North America DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 13: North America DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 14: North America DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 15: North America DNA Synthesis Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America DNA Synthesis Market Value Share (%), By Country, 2025
  • Figure 17: Europe DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 18: Europe DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 19: Europe DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 20: Europe DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 21: Europe DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 23: Europe DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 24: Europe DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 25: Europe DNA Synthesis Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 26: Europe DNA Synthesis Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 27: Asia Pacific DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 28: Asia Pacific DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 29: Asia Pacific DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 30: Asia Pacific DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 31: Asia Pacific DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 34: Asia Pacific DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 35: Asia Pacific DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 36: Asia Pacific DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 37: Latin America DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 38: Latin America DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 39: Latin America DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 40: Latin America DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 41: Latin America DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Latin America DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 43: Latin America DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 44: Latin America DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 45: Latin America DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 46: Latin America DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 47: Middle East & Africa DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 48: Middle East & Africa DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 49: Middle East & Africa DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 50: Middle East & Africa DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 51: Middle East & Africa DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 54: Middle East & Africa DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 55: Middle East & Africa DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 56: Middle East & Africa DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 57: Global DNA Synthesis Market Share Analysis, By Company, 2025